Observational studyInternational journal of clinical oncology2022

Real-world safety and effectiveness of nivolumab for advanced renal cell carcinoma in Japan: a post-marketing surveillance.

Hirotsugu Uemura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.